RADx Tech II Launches
NIBIB is soliciting proposals to further advance SARS-CoV-2 testing technologies to fill specific unmet national needs. Unmet needs include but are not limited to:
- Point-of-care/over-the-counter tests with lab performance
- Tests for multiple pathogens
- Tests adaptable to emerging variants
- Solicitation will only consider proposals for technologies in an advanced stage of readiness that can reach the market in 2021
Application period is June 7-28, 2021.
Summary data on proposals submitted to the RADx Tech and ATP Programs.
- 300 million tests produced
- 150 companies supported
- 23 FDA authorizations
RADx Tech Timeline
See the milestones and success that have unfolded since the beginning of the RADx Tech program.
The RADx Tech and ATP programs leverage the Point of Care Technology Research Network and joined with numerous other federal agencies, offices, NIH institutes, and contractors.
Tests in Development
Descriptions of innovative point of care, home-based, improved clinical laboratory tests, and testing products that are increasing the capacity of testing in the U.S.
Learn about the COVID-19 Testing Impact Calculator, a tool to help organizations plan for and demonstrate how testing and other mitigation measures can curb the spread of the virus. The tool includes a K-12 playbook to help provide guidance for school administrators and an Implementation Guide for any organization developing a testing strategy.
This webinar series hosted by POCTRN provides information on RADx Tech/ATP program activities. Register for upcoming events or watch previous webinars.
View videos about RADx Tech/ATP programs, interviews with the NIBIB Director and more.
Information about studies to evaluate diagnostic tests being developed for COVID-19.